The United States Food and Drug Administration (USFDA) approves Zydus Lifescience for Empagliflozin and Metformin Hydrochloride Tablets in 5 mg/500 mg, 5 mg/1000 mg, 12.5 mg/500 mg, and 12.5 mg/1000 mg.

• Lodha Developers Buys Solidrise for Rs 300 Cr; Shares Jump 1.5%
• Stocks Under F&O Ban: Sammaan Capital, and Others 
• Overnight Stock Market Movements: Key Developments 
• India Approves 25 LMT Wheat, 5 LMT Sugar Export Quota
• US Core Inflation Seen at 5-Year Low Ahead of Friday Report

These tablets are used for proper diet and exercise, which improves glycemic control in adults with two types of diabetes mellitus.

Also, they are used to lower the risk of cardiovascular disease. In India, only Ahmedabad will be manufactured at the formulation facility at SEZ.